Akoya BioSciences Shares Are Trading Higher After the Company Announced That the Company's PhenoCycler Fusion and PhenoImager HT Spatial Proteomics Platforms Will Be Used to Analyze Tissue Samples as Part of the MANIFEST Program.
Akoya BioSciences Shares Are Trading Higher After the Company Announced That the Company's PhenoCycler Fusion and PhenoImager HT Spatial Proteomics Platforms Will Be Used to Analyze Tissue Samples as Part of the MANIFEST Program.
Akoya BioSciences股價上漲，公司宣佈公司的PhenoCycler Fusion和PhenoImager Ht空間蛋白質組學平台將用於MANIFESt計劃中的組織樣本分析。
Akoya BioSciences Shares Are Trading Higher After the Company Announced That the Company's PhenoCycler Fusion and PhenoImager HT Spatial Proteomics Platforms Will Be Used to Analyze Tissue Samples as Part of the MANIFEST Program.
Akoya BioSciences股價上漲，公司宣佈公司的PhenoCycler Fusion和PhenoImager Ht空間蛋白質組學平台將用於MANIFESt計劃中的組織樣本分析。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。